Tickwind
TodayOpportunitiesMarketsAI Chat
EN
Log inSign up
Tickwind

Read every tick. See where the market's blowing.

  • X
  • TelegramChinese
  • Newsletter

Product

  • Markets
  • Theme Zones
  • All stocks
  • Compare
  • Hot stocks
  • Opportunities
  • News
  • Discussion
  • Watchlist
  • What's new

Account

  • Settings
  • Newsletter
  • For writers
  • MCP server
  • Contact
  • Log in
  • Sign up
MarketsTheme ZonesAll stocksCompareHot stocksOpportunitiesNewsDiscussionWatchlistWhat's newSettingsNewsletterFor writersMCP serverContactLog inSign up

© 2026 Tickwind. Not investment advice.

Made for the curious investor.

Home/CLDI/Net margin

Calidi Biotherapeutics, Inc. (CLDI) Net margin

Calidi Biotherapeutics, Inc. (CLDI) net profit margin by fiscal year — reported net income divided by reported revenue.

-64924.4%FY2023
23
Fiscal yearValueYoY
FY2023-64924.4%—

Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.

Source: SEC XBRL filings · For reference only · Not investment advice

More CLDI financial trends

CLDI RevenueCLDI Net incomeCLDI Gross profitCLDI Gross marginCLDI Operating incomeCLDI Operating marginCLDI Operating cash flowCLDI Free cash flowCLDI Capital expendituresCLDI Return on equityCLDI Stock buybacksCLDI Dividends paidCLDI Total assetsCLDI Total liabilitiesCLDI Shareholders’ equityCLDI overview →